Hyperchylomicronemia causes endothelial cell inflammation and increases atherosclerosis

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Atherosclerosis Research

Background:

• The independent role of triglycerides (TGs) in atherosclerosis development remains debated.
• Severe hypertriglyceridemia often coexists with low low-density lipoprotein cholesterol (LDL-C) levels, complicating research.
• Understanding the specific contribution of hyperchylomicronemia is crucial for cardiovascular health.

Purpose of the Study:

• To investigate if hyperchylomicronemia, independent of markedly reduced LDL-C, promotes atherosclerosis.
• To elucidate the mechanisms by which chylomicrons impact vascular disease.
• To determine if elevated chylomicron levels contribute to atherosclerotic lesion development.

Main Methods:

• Created a mouse model with induced lipoprotein lipase (LpL) and LDL receptor (LDLR) deficiency.
• Administered an atherogenic Western-type diet (WD) to the genetically modified mice.
• Quantified atherosclerotic lesions in the brachiocephalic artery and aortic root after 12 weeks.

Main Results:

• Mice with combined LpL and LDLR deficiency exhibited hypertriglyceridemia and elevated cholesterol, primarily in chylomicrons and VLDL.
• Atherosclerotic lesions were significantly more severe in the brachiocephalic artery and aortic root of these mice compared to controls.
• Evidence suggests hyperchylomicronemia induces endothelial cell inflammation in the aorta.

Conclusions:

• Intact chylomicrons are shown to contribute directly to atherosclerosis development.
• This study provides a mechanistic link between postprandial lipemia and vascular disease.
• Hyperchylomicronemia is confirmed as a significant and non-benign factor in cardiovascular pathology.